Efficacy of intralesional pentoxifylline versus intralesional steroid versus intralesional vitamin D in treatment of keloid
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-03799-7 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Sara Ahmed Galal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Department, Faculty of Medicine (Girls), Al-Azhar University, 53, New Cairo, 3rd Zone Fifth, Settlement, Cairo, Egypt. dr…. Hauptthemen laut MEDLINE: Pentoxifylline, Keloid, Vitamin D, Triamcinolone Acetonide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Several treatment modalities have been used for the treatment of keloid scarring but the optimal treatment has not yet been identified. Corticosteroids reduce excessive scarring by reducing collagen synthesis. Vitamin D can curb inflammation by inhibiting the activation and migration of leukocytes. Pentoxifylline is a methyl xanthine derivative initially developed for its vasodilatory properties. Evaluation and comparison between three modalities of treatment for keloid; intralesional vitamin D, pentoxifylline, and steroid. Forty-five patients with keloid lesions were divided into 3 groups; The first group: 15 patients were treated with intralesional triamcinolone acetonide. The second group: 15 patients treated with intralesional pentoxifylline. The third group: 15 patients treated with intralesional vitamin D. The response was evaluated clinically, Vancouver scar scale and patient satisfaction scale. At the end of the study, all groups showed highly statistically significant improvement compared to the baseline. The first group which was treated with triamcinolone acetonide showed excellent and good improvement 53% and 47% respectively. The second group which was treated with pentoxifylline showed excellent and good improvement 6.7% and 73.3% respectively. The third group which was treated with vitamin D showed excellent and good 6.7% and 86.7% respectively. Intralesional vitamin D and pentoxifylline are safe and effective therapeutic options for keloid lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology and Venereology Department, Faculty of Medicine (Girls), Al-Azhar University, 53, New Cairo, 3rd Zone Fifth, Settlement, Cairo, Egypt. drsaragalal@azhar.edu.eg.
- Dermatology and Venereology Department, Faculty of Medicine (Girls), Al-Azhar University, 53, New Cairo, 3rd Zone Fifth, Settlement, Cairo, Egypt.
- Medicine and General Surgery, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Zitieren
APA
Galal, S. A., El-Barbary, R. A., & Madkour, D. K. A. E. W. (2025). Efficacy of intralesional pentoxifylline versus intralesional steroid versus intralesional vitamin D in treatment of keloid. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-03799-7
Vancouver
Galal SA, El-Barbary RA, Madkour DKAEW. Efficacy of intralesional pentoxifylline versus intralesional steroid versus intralesional vitamin D in treatment of keloid. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-03799-7
BibTeX
@article{Galal2025,
author = {Galal, Sara Ahmed and El-Barbary, Rasha Aly and Madkour, Doaa Karam Abd El Wahed},
title = {Efficacy of intralesional pentoxifylline versus intralesional steroid versus intralesional vitamin D in treatment of keloid},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-03799-7}
}
EUVIMED